| DRAC AG - Vimizim 5mg/5ml, Konzentrat zur Herstellung einer Infusionslösung |
| 65370 | | 01 | | Vimizim 5mg/5ml | | Konzentrat zur Herstellung einer Infusionslösung | | A16AB12 | | Elosulfase Alfa | | 19.01.2016 | | |
|
| Composition |
| elosulfasum alfa 5 mg, natrii acetas trihydricus, natrii dihydrogenophosphas monohydricus, arginini hydrochloridum, sorbitolum 100 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 8 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Elosulfasum Alfa | 5mg / 5ml |
| | | | Inactive agents | Dose |
|---|
| Arginine Hydrochloride | | | Sodium Acetate Trihydrate | | | Sodium Dihydrogenophosphate Monohydrate | | | Polysorbatum 20 | | | Sorbitol | 100mg / 5ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | PR | PR | B | | Yes |
|
